Transcriptomic analysis reveals synaptic dysregulation and mitochondrial dysfunction in autism spectrum disorder

This analysis uncovers a distinct molecular signature in ASD, emphasizing the convergence of synaptic abnormalities and metabolic disruption. The findings provide valuable insights into the pathophysiology of ASD and highlight potential targets for biomarker development and therapeutic strategies.